How NR and CoQ10 Supplements Could Benefit People with Kidney Disease

Author Profile Image

- Updated by Jody Mullis
Medically reviewed by Dr. Sidra Samad

  • Nicotinamide riboside (NR) and CoQ10 may boost metabolism and immunity.
  • CoQ10 significantly reduces inflammation markers in the blood.
  • NR potentially enhances mitochondrial function, improving energy production.
  • This study offers new insights into chronic kidney disease (CKD) management.
  • Future research could assess combined effects of NR and CoQ10.

 

 

Why This Matters to Us:

As longevity enthusiasts, we're interested in anything that can improve health and extend life, especially for those with chronic health conditions like CKD. This study suggests that both NR and CoQ10, supplements known for cellular health and energy, might play a role in improving the health of CKD patients. These improvements could translate to better longevity and quality of life, making these supplements worth considering in the context of anti-aging strategies.

The Detail:

Roshanravan and colleagues from the University of California, Davis, conducted a study to evaluate the effects of NR and CoQ10 on patients with chronic kidney disease. With a focus on metabolism and immunity, the study is pivotal because NAD+ precursors like NR are believed to enhance cellular energy, while CoQ10 is known for its role in cellular respiration and energy production.

Their research demonstrated that supplementation with either NR or CoQ10 increased gene activity related to metabolism, which is the body's process of converting food into energy, and immunity, or the system that protects us from illnesses. Specifically, CoQ10 lowered levels of inflammation-related proteins in the blood, such as IL-13 and C-reactive protein (CRP), which are markers often found in higher levels in CKD patients.

NR showed promising results in improving the bioenergetic health index (BHI), a measure that indicates the functional capacity of mitochondria—the powerhouses of cells. Better mitochondrial function means cells can generate energy more efficiently, which is particularly beneficial for individuals with CKD who may experience fatigue and lack of energy.

The study explored how these supplements could modulate gene expression to promote better carbohydrate and lipid (fat) metabolism and enhance immunity. These findings are significant because they suggest a dual action—both metabolic enhancement and inflammation reduction—that could be highly beneficial for people with CKD.

In conclusion, while the study presents exciting findings, it also emphasizes the need for further research. Future investigations could delve into whether combining NR and CoQ10 could offer even greater benefits, such as improved inflammation control and enhanced mitochondrial function. These studies could also explore the effects of these supplements on healthy individuals, aged beyond their prime, to determine their potential in enhancing physical fitness and overall health longevity.